Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (241-250 of 251) with videos related to

Pageof 26
Sort By:
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Journal of Surgical Oncology|January 1, 1987
Gallbladder adenocarcinoma: the prognostic significance of histologic gradeL A Johnson, P T Lavin, Y Y Dayal, et al.
Cancer|March 1, 1983
Carcinoids: the association of histologic growth pattern and survivalL A Johnson, P Lavin, C G Moertel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancerR M Goldberg, A K Hatfield, M Kahn, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1996
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trialJ A Martenson, G Hyland, C G Moertel, et al.
The New England Journal of Medicine|June 19, 1997
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropeniaL C Hartmann, L K Tschetter, T M Habermann, et al.
Annals of Internal Medicine|March 1, 1995
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final reportC G Moertel, T R Fleming, J S Macdonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancerM J O'Connell, J A Laurie, M Kahn, et al.
The American Journal of Medicine|October 1, 1980
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology GroupW D Dewys, C Begg, P T Lavin, et al.
Cancer|July 1, 1978
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group ReportP S Schein, P T Lavin, C G Moertel, et al.
Pageof 26

Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Journal of Surgical Oncology|January 1, 1987
Gallbladder adenocarcinoma: the prognostic significance of histologic gradeL A Johnson, P T Lavin, Y Y Dayal, et al.
Cancer|March 1, 1983
Carcinoids: the association of histologic growth pattern and survivalL A Johnson, P Lavin, C G Moertel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancerR M Goldberg, A K Hatfield, M Kahn, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1996
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trialJ A Martenson, G Hyland, C G Moertel, et al.
The New England Journal of Medicine|June 19, 1997
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropeniaL C Hartmann, L K Tschetter, T M Habermann, et al.
Annals of Internal Medicine|March 1, 1995
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final reportC G Moertel, T R Fleming, J S Macdonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancerM J O'Connell, J A Laurie, M Kahn, et al.
The American Journal of Medicine|October 1, 1980
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology GroupW D Dewys, C Begg, P T Lavin, et al.
Cancer|July 1, 1978
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group ReportP S Schein, P T Lavin, C G Moertel, et al.
Pageof 26